Literature DB >> 25179794

Recalibration of the SCORE risk chart for the Russian population.

Dmitri A Jdanov1, Alexander D Deev, Domantas Jasilionis, Svetlana A Shalnova, Maria A Shkolnikova, Vladimir M Shkolnikov.   

Abstract

Persisting high levels of cardiovascular mortality in Russia present a specific case among developed countries. Application of cardiovascular risk prediction models holds great potential for primary prevention in this country. Using a unique set of cohort follow-up data from Moscow and Saint Petersburg, this study aims to test and recalibrate the Systematic Coronary Risk Evaluation (SCORE) methods for predicting CVD mortality risks in the general population. The study is based on pooled epidemiological cohort data covering the period 1975-2001. The algorithms from the SCORE project were used for the calibration of the SCORE equation for the Moscow and St. Petersburg populations (SCORE-MoSP). Age-specific 10-year cumulative cardiovascular mortality rates were estimated according to the original SCORE-High and SCORE-Low equations and compared to the estimates based on the recalibrated SCORE-MoSP model and observed CVD mortality rates. Ten-year risk prediction charts for CVD mortality were derived and compared using conventional SCORE-High and recalibrated SCORE-MoSP methods. The original SCORE-High model tends to substantially under-estimate 10-year cardiovascular mortality risk for females. The SCORE-MoSP model provided better results which were closer to the observed rates. For males, both the SCORE-High and SCORE-MoSP provided similar estimates which tend to under-estimate CVD mortality risk at younger ages. These differences are also reflected in the risk prediction charts. Using non-calibrated scoring models for Russia may lead to substantial under-estimation of cardiovascular mortality risk in some groups of individuals. Although the SCORE-MoSP provide better results for females, more complex scoring methods involving a wider range of risk factors are needed.

Entities:  

Mesh:

Year:  2014        PMID: 25179794      PMCID: PMC4691263          DOI: 10.1007/s10654-014-9947-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

Review 1.  Risk scoring in the assessment of cardiovascular risk.

Authors:  Andrew Beswick; Peter Brindle
Journal:  Curr Opin Lipidol       Date:  2006-08       Impact factor: 4.776

2.  Choice of time scale and its effect on significance of predictors in longitudinal studies.

Authors:  Michael J Pencina; Martin G Larson; Ralph B D'Agostino
Journal:  Stat Med       Date:  2007-03-15       Impact factor: 2.373

3.  Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.

Authors:  S M Grundy; G J Balady; M H Criqui; G Fletcher; P Greenland; L F Hiratzka; N Houston-Miller; P Kris-Etherton; H M Krumholz; J LaRosa; I S Ockene; T A Pearson; J Reed; R Washington; S C Smith
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998.

Authors:  Hannelore K Neuhauser; Ute Ellert; Bärbel-Maria Kurth
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-10

6.  Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example.

Authors:  Ineke van Dis; Daan Kromhout; Johanna M Geleijnse; Jolanda M A Boer; W M Monique Verschuren
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-04

7.  Collaborative US-USSR study on the prevalence of dyslipoproteinemias and ischemic heart disease in American and Soviet populations. Prepared by the US-USSR Steering Committee for Problem Area 1: the pathogenesis of atherosclerosis.

Authors: 
Journal:  Am J Cardiol       Date:  1977-08       Impact factor: 2.778

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study.

Authors:  D B Shestov; A D Deev; A N Klimov; C E Davis; H A Tyroler
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

10.  Cardiovascular risk factors in the former communist countries. Analysis of 40 European MONICA populations.

Authors:  E Ginter
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

View more
  4 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Operational Definition of Active and Healthy Ageing (AHA): A Conceptual Framework.

Authors:  J Bousquet; D Kuh; M Bewick; T Standberg; J Farrell; R Pengelly; M E Joel; L Rodriguez Mañas; J Mercier; J Bringer; T Camuzat; R Bourret; A Bedbrook; M L Kowalski; B Samolinski; S Bonini; C Brayne; J P Michel; J Venne; P Viriot-Durandal; J Alonso; A Avignon; Y Ben-Shlomo; P J Bousquet; B Combe; R Cooper; R Hardy; G Iaccarino; T Keil; E Kesse-Guyot; I Momas; K Ritchie; J M Robine; C Thijs; C Tischer; B Vellas; A Zaidi; F Alonso; K Andersen Ranberg; V Andreeva; J Ankri; S Arnavielhe; H Arshad; P Augé; C Berr; P Bertone; H Blain; A Blasimme; G J Buijs; D Caimmi; A Carriazo; A Cesario; J Coletta; T Cosco; M Criton; F Cuisinier; P Demoly; S Fernandez-Nocelo; B Fougère; J Garcia-Aymerich; M Goldberg; N Guldemond; Z Gutter; D Harman; A Hendry; D Heve; M Illario; C Jeandel; S Krauss-Etschmann; O Krys; D Kula; D Laune; S Lehmann; D Maier; J Malva; P Matignon; E Melen; G Mercier; G Moda; A Nizinkska; M Nogues; M O'Neill; J Y Pelissier; D Poethig; D Porta; D Postma; F Puisieux; M Richards; C Robalo-Cordeiro; V Romano; F Roubille; H Schulz; A Scott; P Senesse; S Slagter; H A Smit; D Somekh; M Stafford; J Suanzes; A Todo-Bom; J Touchon; V Traver-Salcedo; M Van Beurden; R Varraso; I Vergara; E Villalba-Mora; N Wilson; E Wouters; M Zins
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

3.  Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.

Authors:  Noushin Fahimfar; Akbar Fotouhi; Mohammad Ali Mansournia; Reza Malekzadeh; Nizal Sarrafzadegan; Fereidoun Azizi; Marjan Mansourian; Sadaf G Sepanlou; Mohammad Hassan Emamian; Farzad Hadaegh; Hamidreza Roohafza; Hassan Hashemi; Hossein Poustchi; Akram Pourshams; Tahereh Samavat; Maryam Sharafkhah; Mohammad Talaei; David Van Klaveren; Ewout W Steyerberg; Davood Khalili
Journal:  Int J Health Policy Manag       Date:  2022-02-01

4.  Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts.

Authors:  Viktoria Rücker; Ulrich Keil; Anthony P Fitzgerald; Uwe Malzahn; Christof Prugger; Georg Ertl; Peter U Heuschmann; Hannelore Neuhauser
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.